BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8454062)

  • 1. Purification and characterization of a 90 kDa protein released from human tumors and tumor cell lines.
    Iacobelli S; Bucci I; D'Egidio M; Giuliani C; Natoli C; Tinari N; Rubistein M; Schlessinger J
    FEBS Lett; 1993 Mar; 319(1-2):59-65. PubMed ID: 8454062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The secreted tumor-associated antigen 90K is a potent immune stimulator.
    Ullrich A; Sures I; D'Egidio M; Jallal B; Powell TJ; Herbst R; Dreps A; Azam M; Rubinstein M; Natoli C
    J Biol Chem; 1994 Jul; 269(28):18401-7. PubMed ID: 8034587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human carcinoma-associated antigen (HCA), isolated from the endometrial carcinoma cell line KLE-1 and ascitic fluid of a patient with ovarian carcinoma; comparison with epiglycanin.
    Thingstad T; Haavik S; Hansen K; Sletten K; Codington JF; Barsett H
    Eur J Pharm Sci; 1998 Apr; 6(2):121-9. PubMed ID: 9795029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90K.
    Zeimet AG; Stadlmann S; Natoli C; Widschwendter M; Hermann M; Abendstein B; Daxenbichler G; Offner FA; Iacobelli S; Marth C
    Anticancer Res; 2000; 20(6B):4507-11. PubMed ID: 11205296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and first characterization of the secreted and cellular 52-kDa proteins regulated by estrogens in human-breast cancer cells.
    Capony F; Garcia M; Capdevielle J; Rougeot C; Ferrara P; Rochefort H
    Eur J Biochem; 1986 Dec; 161(2):505-12. PubMed ID: 3780754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoaffinity purification and characterisation of p29--an estrogen receptor related protein.
    Hayward JR; Coffer AI; King RJ
    J Steroid Biochem Mol Biol; 1990 Nov; 37(4):513-9. PubMed ID: 2278835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the tumor antigen 90K domains recognized by monoclonal antibodies SP2 and L3 and preparation and characterization of novel anti-90K monoclonal antibodies.
    Tinari N; D'Egidio M; Iacobelli S; Bowen M; Starling G; Seachord C; Darveau R; Aruffo A
    Biochem Biophys Res Commun; 1997 Mar; 232(2):367-72. PubMed ID: 9125183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells.
    Autiero M; Cammarota G; Friedlein A; Zulauf M; Chiappetta G; Dragone V; Guardiola J
    Eur J Immunol; 1995 May; 25(5):1461-4. PubMed ID: 7774651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative structural analysis of human and rat 65 kDa tumor-associated phosphoproteins.
    Mirowski M; Walaszek Z; Sherman U; Hanausek M
    Int J Biochem; 1993 Dec; 25(12):1865-71. PubMed ID: 8138024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A folate binding protein in ascitic fluid, serum and ovarian tissue of patients with ovarian adenocarcinoma immunoreacts with antibodies against human milk folate binding protein.
    Holm J; Hansen SI; Høier-Madsen M; Helkjaer PE
    Biosci Rep; 1998 Apr; 18(2):49-57. PubMed ID: 9743473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of 66-kDa glycoprotein from human breast carcinoma.
    Feng R; Liu X; Guo Z; Li J
    Cancer Sci; 2007 Sep; 98(9):1344-9. PubMed ID: 17640306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.
    Pedersen N; Schmitt M; Rønne E; Nicoletti MI; Høyer-Hansen G; Conese M; Giavazzi R; Dano K; Kuhn W; Jänicke F
    J Clin Invest; 1993 Nov; 92(5):2160-7. PubMed ID: 8227331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune stimulatory protein 90K increases major histocompatibility complex class I expression in a human breast cancer cell line.
    Natoli C; Iacobelli S; Kohn L
    Biochem Biophys Res Commun; 1996 Aug; 225(2):617-20. PubMed ID: 8753808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and analysis of a human sarcoma associated antigen.
    Gupta NK; Hirshaut Y; Schmall B; Feit C
    Cancer Lett; 1993 May; 69(3):173-80. PubMed ID: 8513443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of mouse brain necdin.
    Maruyama E
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):895-901. PubMed ID: 8615786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of two proteins copurifying with carcinoembryonic antigen.
    Grunert F; Abuharfeil N; Luckenbach GA; von Kleist S
    Tumour Biol; 1984; 5(5):221-32. PubMed ID: 6442454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization, molecular cloning and expression of megakaryocyte potentiating factor.
    Yamaguchi N; Yamamura Y; Konishi E; Ueda K; Kojima T; Hattori K; Oheda M; Imai N; Taniguchi Y; Tamura M; Ochi N
    Stem Cells; 1996; 14 Suppl 1():62-74. PubMed ID: 11012204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate receptor in malignant effusions of ovarian carcinoma.
    Holm J; Hansen SI; Høier-Madsen M; Helkjaer PE; Bzorek M
    APMIS; 1995 Sep; 103(9):663-70. PubMed ID: 7488388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of immunosuppressive (IS) substance obtained from ascitic fluids of patients with gastrointestinal cancer.
    Fujii M; Takahashi N; Hayashi H; Matsunaga K; Yoshikumi C
    Clin Biochem; 1987 Jun; 20(3):183-9. PubMed ID: 3652440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a 54 kDa, alpha 1-antitrypsin-like protein isolated from ascitic fluid of an endometrial cancer patient.
    Tanaka N; Sekiya S; Takamizawa H; Kato N; Moriyama Y; Fujimura S
    Jpn J Cancer Res; 1991 Jun; 82(6):693-700. PubMed ID: 1906855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.